Article

A pharmacokinetic/pharmacodynamic mathematical model accurately describes the activity of voriconazole against Candida spp. in vitro.

Department of Pharmaceutics, University of Florida College of Pharmacy, Gainesville, FL, USA.
International Journal of Antimicrobial Agents (Impact Factor: 4.42). 05/2008; 31(4):369-74. DOI: 10.1016/j.ijantimicag.2007.11.015
Source: PubMed

ABSTRACT We developed a pharmacokinetic/pharmacodynamic (PK/PD) mathematical model that fits voriconazole time-kill data against Candida isolates in vitro and used the model to simulate the expected kill curves for typical intravenous and oral dosing regimens. A series of Emax mathematical models were used to fit time-kill data for two isolates each of Candida albicans, Candida glabrata and Candida parapsilosis. PK parameters extracted from human data sets were used in the model to simulate kill curves for each isolate. Time-kill data were best fit by using an adapted sigmoidal Emax model that corrected for delays in candidal growth and the onset of voriconazole activity, saturation of the number of Candida and the steepness of the concentration-response curve. The rates of maximal killing by voriconazole (kmax) were highly correlated with the growth rates (ks) of the isolates (Pearson's correlation coefficient=0.9861). Simulations using PK parameters derived from the human data sets showed fungistatic effects against each of the isolates. In conclusion, we demonstrated that the activity of voriconazole against Candida isolates can be accurately described using a mathematical model. In the future, it might be possible to devise optimal dosing regimens of voriconazole using the model and PK data collected in vivo.

0 Bookmarks
 · 
68 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Although many clinicians and researchers work to understand cancer, there has been limited success to effectively combine forces and collaborate over time, distance, data and budget constraints. Here we present a workflow template for multidisciplinary cancer therapy that was developed during the 2nd Annual Workshop on Cancer Systems Biology sponsored by Tufts University, Boston, MA in July 2012. The template was applied to the development of a metronomic therapy backbone for neuroblastoma. Three primary groups were identified: clinicians, biologists, and scientists (mathematicians, computer scientists, physicists and engineers). The workflow described their integrative interactions; parallel or sequential processes; data sources and computational tools at different stages as well as the iterative nature of therapeutic development from clinical observations to in vitro, in vivo, and clinical trials. We found that theoreticians in dialog with experimentalists could develop calibrated and parameterized predictive models that inform and formalize sets of testable hypotheses, thus speeding up discovery and validation while reducing laboratory resources and costs. The developed template outlines an interdisciplinary collaboration workflow designed to systematically investigate the mechanistic underpinnings of a new therapy and validate that therapy to advance development and clinical acceptance.
    Cancer Research 08/2013; · 9.28 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Clinical practice guidelines recommend performing follow-up cultures for patients with candidemia in order to determine the time when Candida is cleared from the bloodstream. Since this requires collecting blood cultures from patients undergoing antifungal treatment, we evaluated two blood culture bottles (Bactec™ Mycosis IC/F (MICF), specifically adapted to the growth of fungi, and Bactec™ Plus Aerobic/F (PAF) containing resins to inactivate anti-infective agents) as to their effectiveness to detect C. albicans and C. glabrata when seeded in concentrations of 1 cfu/ml and 10 cfu/ml, respectively, together with human whole blood and different antifungal agents in therapeutic peak serum concentrations (Cmax). Significant differences between MICF and PAF vials for the detection of Candida spp. were found when inoculated with caspofungin (0/12 vs. 8/12; p<0.001) and amphotericin B (3/12 vs. 12/12; p<0.001). Inoculation of both fluconazole and voriconazole did not influence the effectiveness of detection in both MICF and PAF bottles (p=1.0). Neither MICF nor PAF bottles detected Candida spp. reliably when seeded together with anidulafungin (1/12 vs. 1/12; p=1.0) or micafungin (0/12 vs. 1/12; p=1.0). The time-to-positivity of both bottles when antifungal agents were added was significantly prolonged compared to controls without antimycotic drugs (p<0.001). Overall, the results of this in vitro study indicate that PAF bottles detected Candida spp. more reliably compared with MICF bottles when supplemented with certain antifungal agents. In consequence, clinical studies should now evaluate whether this holds true when taking blood cultures from patients undergoing antifungal treatment.
    Journal of clinical microbiology 08/2013; · 4.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: More than 30% of E. coli strains sampled from pig farms in Denmark over the last five years were resistant to the commonly used antimicrobial tetracycline. This raises a number of questions: How is this high level sustained if resistant bacteria have reduced growth rates? Given that there are multiple susceptible and resistant bacterial strains in the pig intestines, how can we describe their coexistence? To what extent does the composition of these multiple strains in individual pigs influence the total bacterial population of the pig pen? What happens to a complex population when antimicrobials are used? To investigate these questions, we created a model where multiple strains of bacteria coexist in the intestines of pigs sharing a pen, and explored the parameter limits of a stable system; both with and without an antimicrobial treatment. The approach taken is a deterministic bacterial population model with stochastic elements of bacterial distributions and transmission. The rates that govern the model are process-oriented to represent growth, excretion, and uptake from environment, independent of herd and meta-population structures. Furthermore, an entry barrier and elimination process for the individual strains in each pig were implemented. We demonstrate how competitive growth between multiple bacterial strains in individual pigs, and the transmission between pigs in a pen allow for strains of antimicrobial resistant bacteria to persist in a pig population to different extents, and how quickly they can become dominant if antimicrobial treatment is initiated. The level of spread depends in a non-linear way of the parameters that govern excretion and uptake. Furthermore, the sampling of initial distributions of strains and stochastic transmission events give rise to large variation in how homogenous and how resistant the bacterial population becomes. Most important: resistant bacteria are demonstrated to survive with a disadvantage in growth rate of well over 10%.
    PLoS ONE 01/2014; 9(7):e100458. · 3.53 Impact Factor

Full-text (2 Sources)

Download
14 Downloads
Available from
Jun 3, 2014